Gastritis Treatment Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2024

GASTRITIS TREATMENT MARKET
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2016–2024
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Gastritis Treatment Market Overview
Gastritis is the irritation, or inflammation, or erosion of the stomach lining. Gastritis may be
acute or chronic. The disease may show some symptoms or the symptoms may be dormant.
Usually, the symptoms include upper abdominal pain, nausea, and vomiting. Gastritis may lead
to stomach tumors, bleeding, and stomach ulcers. Gastritis is usually caused by the bacteria
helicobacter pylori or by the use of nonsteroidal anti-inflammatory drugs or NSAIDs. Other
possible causes include smoking, cocaine, alcohol, and autoimmune diseases, among others.
Treatment of gastritis includes H2 blockers, antacids, or proton pump inhibitors. In an acute
gastritis attack, consumption of viscous lidocaine may be of assistance. If H. pylori are present, it
may be cured with a combination drug therapy of antibiotics such as clarithromycin and
amoxicillin. Gastritis can be cured by proper treatment; hence the demand of gastritis treatment
is poised to rise in the foreseeable future.
Request Sample Copy of the Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/148
Chronic gastritis is one of the major diseases that affect a significant population of the globe and
its prevalence is rising, according to a research report published in National Center for
Biotechnology Information. It is estimated that nearly half the population of the world suffers
from infection by helicobacter pylori, one of the main agent causing gastritis. There has been a
growing concern about the prevalence of the disease around the world.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Gastritis Treatment Market Taxonomy
On the basis of drug class, the global gastritis treatment market is classified into:
• Acid blocking medicines
• Antibiotics
• Antacids
• Acid reducing medicines
• Others
On the basis of end user, the global gastritis treatment market is classified into:
• Government
• Hospitals
• Medical Practitioners
• Others
Request a Customization:
https://www.coherentmarketinsights.com/insight/request-customization/148
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Increasing prevalence of chronic gastritis, especially in the geriatric population offers
promising growth for gastritis treatment market
There has been an increasing prevalence of gastritis, especially in the geriatric people around
the globe. According to a report by National Center for Biotechnology Information, there were
about 90 million new cases of gastritis in 2013. Gastritis and deodenitis (inflammation of the
duodenum) caused about 60,000 deaths in 2013. As life expectancy has been increasing, the
geriatric population of the globe is also on the rise. According to the same report, the
prevalence of gastritis increase with age. Therefore, the demand for gastritis treatment will
increase at a steady rate over the forecast period.
Get Exclusive Discount on this CMI Report:
https://www.coherentmarketinsights.com/insight/request-discount/148
The gastritis treatment market is highly fragmented in nature. Many companies are investing
heavily in their research and development activities to come up with different treatments of
the disease. Companies operating in the gastritis treatment market in the current scenario are
Otsuka Indonesia PT, AstraZeneca PLC, Zydus Cadila Healthcare Limited, Novartis AG, and
others.
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on
assisting its plethora of clients achieve transformational growth by helping them make critical business
decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our
client base includes players from across all business verticals in over 150 countries worldwide. We are
uniquely positioned to help businesses around the globe deliver practical and lasting results through
various recommendations about operational improvements, technologies, emerging market trends and
new working methods. We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We meticulously study
emerging trends across various industries at both the global and regional levels to identify new
opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI
SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
 Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry
 Component Providers and System Integrators
 Private and Government organization
 Distributors, Retailors and Value Added Resellers
 Outsourcing Companies
 Healthcare IT Solutions Developers
 Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY
STUDIES
Insights Published
Per Year
GLOBAL
REPORTS
150+
Consulting Projects
Till Date
COUNTRY
ANALYSIS
CONSULT
PROJECTS
125+
Clients Worldwide
Per Year
110+
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals,
including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in
order to result in the best possible market research reports across various industries worldwide. Based on our unmatched
expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better
outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure
sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of
opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702
© Coherent market Insights. All Rights Reserved

Gastritis is the irritation, or inflammation, or erosion of the stomach lining. Gastritis may be acute or chronic. The disease may show some symptoms or the symptoms may be dormant. Usually, the symptoms include upper abdominal pain, nausea, and vomiting. Gastritis may lead to stomach tumors, bleeding, and stomach ulcers. Gastritis is usually caused by the bacteria helicobacter pylori or by the use of nonsteroidal anti-inflammatory drugs or NSAIDs. Other possible causes include smoking, cocaine, alcohol, and autoimmune diseases, among others. Treatment of gastritis includes H2 blockers, antacids, or proton pump inhibitors. In an acute gastritis attack, consumption of viscous lidocaine may be of assistance. If H. pylori are present, it may be cured with a combination drug therapy of antibiotics such as clarithromycin and amoxicillin. Gastritis can be cured by proper treatment; hence the demand of gastritis treatment is poised to rise in the foreseeable future. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/148